Your browser doesn't support javascript.
loading
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection.
Goto, Takeyuki; Chong, Yong; Tani, Naoki; Susai, Natsumi; Yoshinaga, Tomoyo; Sasaki, Tomoki; Taniguchi, Masahiro; Kusakabe, Takahiro; Shimono, Nobuyuki; Akashi, Koichi; Ikematsu, Hideyuki.
Afiliação
  • Goto T; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
  • Chong Y; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan. Electronic address: jeong.yong.342@m.kyushu-u.ac.jp.
  • Tani N; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
  • Susai N; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan.
  • Yoshinaga T; Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan.
  • Sasaki T; R&D Department, KAICO Ltd., Fukuoka, Japan; Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
  • Taniguchi M; R&D Department, KAICO Ltd., Fukuoka, Japan.
  • Kusakabe T; Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
  • Shimono N; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
  • Akashi K; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
  • Ikematsu H; Ricerca Clinica Co., Fukuoka, Japan.
Vaccine ; 41(47): 7019-7025, 2023 11 13.
Article em En | MEDLINE | ID: mdl-37858449

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunidade Humoral / COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunidade Humoral / COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão